{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:59:06Z","timestamp":1793383146895,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s00467-006-0227-y","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T11:24:35Z","timestamp":1160047475000},"page":"57-63","source":"Crossref","is-referenced-by-count":72,"title":["Cyclosporin therapy in patients with Alport syndrome"],"prefix":"10.1007","volume":"22","author":[{"given":"Marina","family":"Charbit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire","family":"Gubler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Dechaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Gagnadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gr\u00fcnfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Niaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,1]]},"reference":[{"key":"227_CR1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE (1998) Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9:1736\u20131750","journal-title":"J Am Soc Nephrol"},{"key":"227_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.2349482","volume":"248","author":"DF Barker","year":"1990","unstructured":"Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224\u20131227","journal-title":"Science"},{"key":"227_CR3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.V75702","volume":"7","author":"N Heiskari","year":"1996","unstructured":"Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Gronhagen-Riska C, Neumann HP, Trembath R, Tryggvason K (1996) Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: A study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol 7:702\u2013709","journal-title":"J Am Soc Nephrol"},{"key":"227_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1172\/JCI117073","volume":"93","author":"C Antignac","year":"1994","unstructured":"Antignac C, Knebelmann B, Druout L, Gros F, Deschenes G, Hors-Cayla MC, Zhou J, Tryggvason K, Grunfeld JP, Broyer M, Gubler MC (1994) Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells: Correlation with disease expression. J Clin Invest 93:1195\u20131207","journal-title":"J Clin Invest"},{"key":"227_CR5","first-page":"203","volume":"13","author":"HJ Rumpelt","year":"1980","unstructured":"Rumpelt HJ (1980) Hereditary nephropathy (Alport syndrome): correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13:203\u2013207","journal-title":"Clin Nephrol"},{"key":"227_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng0994-77","volume":"8","author":"T Mochizuki","year":"1994","unstructured":"Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ (1994) Identification of mutations in the a3(IV) and a4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77\u201381","journal-title":"Nat Genet"},{"key":"227_CR7","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","volume":"65","author":"C Pescucci","year":"2004","unstructured":"Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A (2004) Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 65:1598\u20131603","journal-title":"Kidney Int"},{"key":"227_CR8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1523-1755.2000.00358.x","volume":"58","author":"FT Loop van der","year":"2000","unstructured":"van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schroder CH, Smeets HJ (2000) Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58:1870\u20131875","journal-title":"Kidney Int"},{"key":"227_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: Natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"227_CR10","first-page":"67","volume":"65","author":"V Valli","year":"1991","unstructured":"Valli V, Baumal R, Thorner P, Jacobs R, Marrano P, Davies C, Qizilbash B, Clarke H (1991) Dietary modification reduces splitting of glomerular basement membranes and delays death due to renal failure in canine X-linked hereditary nephritis. Lab Invest 65:67\u201373","journal-title":"Lab Invest"},{"key":"227_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0021-9975(97)80016-3","volume":"117","author":"K-M Grodecki","year":"1997","unstructured":"Grodecki K-M, Gains M-J, Baumal R, Osmond DH, Cotter B, Valli VE, Jacobs RM (1997) Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme(ACE) inhibitor. J Comp Pathol 117:209\u2013225","journal-title":"J Comp Pathol"},{"key":"227_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O Gross","year":"2003","unstructured":"Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63:438\u2013446","journal-title":"Kidney Int"},{"key":"227_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s004310051301","volume":"159","author":"W Proesmans","year":"2000","unstructured":"Proesmans W, Knockaert H, Trouet D (2000) Enalapril in pediatric patients with Alport syndrome: 2 years experience. Eur J Pediatr 159:430\u2013433","journal-title":"Eur J Pediatr"},{"key":"227_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00467-003-1366-z","volume":"19","author":"W Proesmans","year":"2004","unstructured":"Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatric Nephrol 19:271\u2013275","journal-title":"Pediatric Nephrol"},{"key":"227_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF00866293","volume":"6","author":"L Callis","year":"1992","unstructured":"Callis L, Vila A, Nieto J, Fortuny G (1992) Effects of cyclosporin A on proteinuria in patients with Alport\u2019s syndrome. Pediatr Nephrol 6:140\u2013144","journal-title":"Pediatr Nephrol"},{"key":"227_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1046\/j.1523-1755.1999.0550031051.x","volume":"55","author":"L Callis","year":"1999","unstructured":"Callis L, Vila A, Carrera M, Nieto J (1999) Long-term effects of cyclosporin A in Alport\u2019s syndrome. Kidney Int 55:1051\u20131056","journal-title":"Kidney Int"},{"key":"227_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","volume":"14","author":"D Chen","year":"2003","unstructured":"Chen D, Jefferson B, Harvey SJ, Zheng K, Gartley CJ, Jacobs RM, Thorner PS (2003) Cyclosporin A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 14:690\u2013698","journal-title":"J Am Soc Nephrol"},{"key":"227_CR18","first-page":"14","volume":"22","author":"MC Gubler","year":"1992","unstructured":"Gubler MC, Antignac C, Desch\u00eanes G, Knebelmann B, Hors-Cayla MC, Gr\u00fcnfeld JP, Broyer M, Habib R (1992) Genetic, clinical and morphologic heterogeneity in Alport syndrome. Adv Nephrol Necker Hosp 22:14\u201334","journal-title":"Adv Nephrol Necker Hosp"},{"key":"227_CR19","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","volume":"61","author":"K Iijima","year":"2002","unstructured":"Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N (2002) Risk factors for cyclosporin-induced tubulointerstitial lesions in children with minimal change nephritic syndrome. Kidney Int 61:1801\u20131805","journal-title":"Kidney Int"},{"key":"227_CR20","first-page":"424","volume":"55","author":"K Kano","year":"1999","unstructured":"Kano K, Kyo K, Yamada Y, Ito S, Ando T, Arisaka O (1999) Comparison between pre-and posttreatment clinical and renal biopsies in children receiving low dose cyclosporin-A for 2 years for steroid-dependant nephritic syndrome. Clin Nephrol 55:424\u2013425","journal-title":"Clin Nephrol"},{"key":"227_CR21","first-page":"141","volume":"42","author":"R Habib","year":"1994","unstructured":"Habib R, Niaudet P (1994) Comparison between pre- and posttreatment renal biopsies in children receiving cyclosporin for idiopathic nephrosis. Clin Nephrol 42:141\u2013146","journal-title":"Clin Nephrol"},{"key":"227_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.V74543","volume":"7","author":"MJ Gregory","year":"1996","unstructured":"Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE (1996) Long-term cyclosporin therapy for pediatric nephritic syndrome: a clinical and histological analysis. J Am Soc Nephrol 7:543\u2013549","journal-title":"J Am Soc Nephrol"},{"key":"227_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/00005344-199802000-00019","volume":"31","author":"F Schmitt","year":"1998","unstructured":"Schmitt F, Martinez F, Brillet G, Nguyen-Khoa T, Brouard R, Sissmann J, Lacour B, Grunfeld JP (1998) Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects. J Cardiovasc Pharmacol 31:314\u2013321","journal-title":"J Cardiovasc Pharmacol"},{"key":"227_CR24","first-page":"357","volume":"46","author":"R Oberbauer","year":"1996","unstructured":"Oberbauer R, Haas M, Mayer G (1996) Proteinuria as consequence of altered glomerular permselectivity-clinical implications. Clin Nephrol 46:357\u2013361","journal-title":"Clin Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0227-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-006-0227-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0227-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0227-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:36:41Z","timestamp":1627853801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-006-0227-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1007\/s00467-006-0227-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}